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Backgrounds: To analyse the effectiveness of cardiac resynchronization therapy (CRT) related to the viability in the segment of left ventricular (LV) 
lead position defined by myocardial deformation imaging.
Background. Echocardiographic myocardial deformation analysis allows determination of LV lead position as well as extent of myocardial viability.
Methods:  Myocardial deformation imaging based on tracking of acoustic markers within 2D echo images (GE Ultrasound) was performed in 65 
heart failure patients (54±6 years, 41 men) before and 12 months after CRT implantation. In a 16 segment model, the LV lead position was defined 
based on the segmental strain curve with earliest peak strain while the CRT system was programmed to pure pure LV pacing. Non-viability of a 
segment (transmural scar formation) was assumed if the peak systolic circumferential strain was >-11.1%.
Results:  In 47 patients the LV lead was placed in a viable segment and in 18 patients in a non-viable segment. At 12 months follow-up there was 
greater decrease of LV enddiastolic volumes (58±13 vs. 44±12 ml, p=0.0388), greater increase of LV ejection fraction (11±4 vs. 5±4 %, p=0.0343) 
and peak oxygen consumption (2.5±0.9 vs. 1.7±1.1 ml/kg/min, p=0.0465) in the viable compared to the non-viable group. Considering only 
patients with ischemic heart disease differences between viable and non-viable LV lead position group were even greater.
Conclusions:  Preserved viability in the segment of the CRT LV lead position results in greater LV reverse remodeling and functional benefit at 12 
months follow-up.
